文献速递肝病消化道出血

开发并验证预后评分以识别肝硬化急性静脉曲张出血患者中预防性TIPS的最佳候选者

Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding.
PubMed 文献 · Hepatology · 2023-08-18

基于中国12家医院1554例肝硬化急性静脉曲张出血患者开发预测6周和1年死亡率的评分,并联合治疗交互项预测p-TIPS的疗效差异;外部验证集445例来自6家医院,模型区分度良好,有助于识别可从p-TIPS获益的个体。

要点

  • 开发了包含年龄、白蛋白、胆红素、INR、白细胞、肌酐和钠的预后评分,预测6周和1年死亡率。
  • 该评分联合治疗及交互项可预测p-TIPS的疗效差异,区分度良好(6周/1年获益c指数0.696/0.665)。
  • 外部验证集445例中6周/1年获益c指数分别为0.675/0.672,模型校准良好。

核心结论

  • 开发并验证的临床预测模型有助于识别可从p-TIPS获益的个体,可能指导临床决策。

研究设计与样本

  • 推导队列纳入中国12家医院2010年至2017年1554例肝硬化急性静脉曲张出血患者,其中内镜联合药物治疗1264例,p-TIPS治疗290例。
  • 验证数据集纳入中国6家医院2017年至2019年445例肝硬化急性静脉曲张出血患者。
  • 采用竞争风险回归开发评分,并用bootstrap法进行内部验证。

主要发现

  • 预测6周和1年死亡率的评分包含年龄、白蛋白、胆红素、国际标准化比值、白细胞、肌酐和钠。
  • 评分内部验证区分度良好,6周/1年一致性指数分别为0.766/0.740,且优于其他现有模型。
  • 评分联合治疗及交互项预测p-TIPS疗效差异,6周/1年获益c指数分别为0.696/0.665,校准良好。
  • 外部验证集6周/1年获益c指数分别为0.675/0.672。

关键数值与推荐

  • Baveno VII研讨会推荐对治疗失败高风险的肝硬化急性静脉曲张出血患者使用p-TIPS。
  • 预测6周和1年死亡率的评分包含年龄、白蛋白、胆红素、国际标准化比值、白细胞、肌酐和钠。
  • 推导队列内部验证6周/1年一致性指数分别为0.766/0.740。
  • 预测p-TIPS疗效的模型6周/1年获益c指数分别为0.696/0.665。
  • 外部验证集6周/1年获益c指数分别为0.675/0.672。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIM: Baveno VII workshop recommends the use of preemptive TIPS (p-TIPS) in patients with cirrhosis and acute variceal bleeding (AVB) at high- risk of treatment failure. However, the criteria defining "high-risk" have low clinical accessibility or include subjective variables. We aimed to develop and externally validate a model for better identification of p-TIPS candidates. APPROACH AND RESULTS: The derivation cohort included 1554 patients with cirrhosis and AVB who were treated with endoscopy plus drug (n = 1264) or p-TIPS (n = 290) from 12 hospitals in China between 2010 and 2017. We first used competing risk regression to develop a score for predicting 6-week and 1-year mortality in patients treated with endoscopy plus drugs, which included age, albumin, bilirubin, international normalized ratio, white blood cell, creatinine, and sodium. The score was internally validated with the bootstrap method, which showed good discrimination (6 wk/1 y concordance-index: 0.766/0.740) and calibration, and outperformed other currently available models. In the second stage, the developed score was combined with treatment and their interaction term to predicate the treatment effect of p-TIPS (mortality risk difference between treatment groups) in the whole derivation cohort. The estimated treatment effect of p-TIPS varied substantially among patients. The prediction model had good discriminative ability (6 wk/1 y c -for-benefit: 0.696/0.665) and was well calibrated. These results were confirmed in the validation dataset of 445 patients with cirrhosis with AVB from 6 hospitals in China between 2017 and 2019 (6-wk/1-y c-for-benefit: 0.675/0.672). CONCLUSIONS: We developed and validated a clinical prediction model that can help to identify individuals who will benefit from p-TIPS, which may guide clinical decision-making.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lv Y, Bai W, Zhu X, et al. Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding. Hepatology. 2023. PMID: 37594323. doi:10.1097/HEP.0000000000000548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。